Jan Marini Skin Research Announces the Launch of Retinol Plus Mask

September 26, 2013

Amplify Anti-aging Results and Say Goodbye to Wrinkles

San Jose, California (PRWEB) September 26, 2013

Jan Marini Skin Research, Inc. (JMSR), a leading provider of professional skincare and aesthetic solutions, announced its second new product release in two months – Retinol Plus Mask.

The advanced new mask enhances product penetration to deliver high concentration retinol, anti-aging peptides, antioxidants, skin-conditioning agents and advanced hydrators directly into the skin for maximum benefit across all skin types. Retinol Plus Mask immediately begins to smooth and refine the surface for a brilliant polished appearance while simultaneously decreasing the appearance of fine lines and wrinkles, sun-damage, hyperpigmentation and acne. Used only 1-2 times per week, Retinol Plus Mask greatly enhances the results of any skin care routine.

Jan Marini, CEO, stated, “Retinoids deliver dramatic results and Retinol Plus Mask enhances these with increased penetration plus a host of additional impressive and synergistic anti-aging technologies. The results are remarkable! Retinol Plus Mask can be used by even the most sensitive skin types and is already one of my must-have products.”

Retinol Plus Mask is available now for $90. Find your nearest retailer at http://www.janmarini.com.

About Jan Marin Skin Research, Inc.

San Jose, CA-based Jan Marini Skin Research, Inc. (JMSR) is a recognized leader and innovator of professional skin care. In addition to multiple patented formulations, JMSR's track-record of technological firsts includes, but is not limited to, topical TGF beta-1, antioxidant sunscreen, topical resveratrol and cosmetic lash enhancement. JMSR products and its Skin Care Management System are used and trusted by professionals worldwide. For more information, visit http://www.janmarini.com or contact the company at (800) 347-2223.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11164191.htm

Source: prweb

comments powered by Disqus